Related Experiment Video
Updated: Jul 29, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Revascularization in advanced stable coronary artery disease
1Cardiovascular Institute, Mount Sinai Medical Center, New York, New York 10029, USA.
Insights
Clinicians can use survival data to guide revascularization decisions for stable coronary artery disease (CAD). Advanced CAD with left ventricular dysfunction or ischemia favors aggressive treatment like coronary artery bypass grafting (CABG).
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Interventional Cardiology
Background:
- Identifying stable coronary artery disease (CAD) patients who benefit from revascularization is clinically challenging.
- Current treatment strategies require refinement for optimal patient outcomes in advanced CAD.
Purpose of the Study:
- To develop a clinical guide for revascularization decisions in advanced stable CAD based on survival data.
- To differentiate patients who benefit from aggressive revascularization versus medical therapy alone.
Main Methods:
- Analysis of survival data to establish criteria for revascularization.
- Evaluation of factors including advanced CAD, left ventricular (LV) dysfunction, and significant ischemia.
- Comparison of outcomes for coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA).
Main Results:
- Survival data support CABG recommendation with at least two factors: advanced CAD, LV dysfunction, and significant ischemia.
- CABG is the preferred treatment for advanced CAD with LV dysfunction or left main coronary artery disease.
- For advanced CAD with normal LV function but significant ischemia, CABG and PTCA offer similar survival; PTCA has higher repeat revascularization rates.
Conclusions:
- A survival data-driven approach aids revascularization decisions in advanced stable CAD.
- Patient-specific factors and preferences influence the choice between CABG and PTCA when survival outcomes are similar.
Abstract:
Identifying patients with stable coronary artery disease (CAD) who benefit from revascularization is a challenge for the clinician. Based on survival data, we have devised a guide to help the clinician decide which patients with advanced stable CAD should be treated more aggressively with revascularization and which patients may be followed with medical therapy alone. Survival data support the recommendation of coronary artery bypass grafting (CABG) when at least two of the following factors are present: advanced CAD, left ventricular (LV) dysfunction and significant ischemia. For patients with advanced CAD and LV dysfunction, or left main coronary artery disease, CABG remains the treatment of choice. In patients with normal LV function, but advanced CAD and significant ischemia, percutaneous transluminal coronary angioplasty (PTCA) and CABG appear to provide similar survival outcomes. While CABG is more invasive and is associated with a longer recovery period, PTCA is associated with more repeat revascularization procedures on follow-up than CABG. Thus, while the recommendation for revascularization in advanced stable CAD is made based on survival data, in some patients the choice of revascularization procedure may depend on the needs and preferences of the individual patient.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care

